

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 30, 26 | Zillmer John J | director | A-Award | 131 | — |
| Sep 30, 26 |
| Whalen Julie |
| director |
| A-Award |
| 131 |
| — |
| Sep 30, 26 | Vautrinot Suzanne M | director | A-Award | 131 | — |
| Sep 30, 26 | Nowell Lionel L Iii | director | A-Award | 131 | — |
| Sep 30, 26 | Mckibben Tracy B | director | A-Award | 131 | — |
| Sep 30, 26 | Maclennan David | director | A-Award | 46 @ $276.36 | $12.81K |
| Sep 30, 26 | Maclennan David | director | A-Award | 131 | — |
| Sep 30, 26 | Larson Michael | director | A-Award | 131 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 2, 2026 | 2026-10-02 17:08:19 | View |
| 4 | Oct 2, 2026 | 2026-10-02 17:05:05 | View |
| 4 | Oct 2, 2026 | 2026-10-02 17:03:30 | View |
| 4 | Oct 2, 2026 | 2026-10-02 17:02:07 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:59:39 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:55:58 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:51:55 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:50:14 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:48:04 | View |
| 4 | Oct 2, 2026 | 2026-10-02 16:44:55 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | ECL | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 38.7x | 41.2x · sector 16.6x | Elevated |
| Forward P/E (FY26E) | 35.6x | EPS est. 8.15 | In line |
| Price / Book | 8.1x | 7.5x | In line |
| Price / Sales | 4.8x | 4.1x | Elevated |
| EV / EBITDA | 25.0x | 22.9x | In line |
| Return on equity | 21.4% | — | Top tier |
| Gross margin | 44.1% | 41.5% | In line |
| Debt / Equity | 1.37 | 1.10 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 4.15 | Safe zone |
Discounted cash flow model
Current price $290.28
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 5, 26 | UBS | maintain | Buy | Buy |
| Jul 30, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 29, 26 | BMO Capital | maintain | Outperform | Outperform |
| Jul 29, 26 | JP Morgan | maintain | Overweight | Overweight |
| Jul 29, 26 | Mizuho | maintain | Outperform | Outperform |
| Jul 17, 26 | Oppenheimer | upgrade | Perform | Outperform |
| Jul 9, 26 | Deutsche Bank | maintain | Buy | Buy |
| Jul 7, 26 | RBC Capital | maintain | Outperform | Outperform |
| Jun 24, 26 | Citigroup | maintain | Buy | Buy |
Stock news · updated daily
Besides Wall Street's top-and-bottom-line estimates for Ecolab (ECL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
ECL gears up for Q3 earnings with strong growth prospects in AI infrastructure, Life Sciences and pricing, but rising costs could pressure margins.
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | 2.08 | 2.09 | Beat 0.5% | $4.42B |
| Apr 28, 2026 | 1.70 | 1.70 | Beat 0.0% | $4.07B |
| Feb 10, 2026 | 2.07 | 2.08 | Beat 0.5% | $4.19B |
| Oct 28, 2025 | 2.07 | 2.07 | Beat 0.0% | $4.17B |
| Jul 29, 2025 | 1.90 | 1.89 | Miss -0.5% | $4.03B |
| Apr 29, 2025 | 1.50 | 1.50 | Beat 0.0% | $3.69B |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 60.74 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 74.60 | Oscillator | Neutral |
| Williams %R (14) | -30.07 | Oscillator | Neutral |
| MACD (12, 26, 9) | 3.42 (Hist 0.81) | Oscillator | Strong Buy |
| Average Directional Index (14) | 20.74 (+DI 25.9 / -DI 14.3) | Trend | Buy |
| EMA 20 | 284.54 | MA | Buy |
| SMA 20 | 282.94 | MA | Buy |
| EMA 50 | 280.77 | MA | Strong Buy |
| SMA 50 | 280.44 | MA | Strong Buy |
| SMA 200 | 275.39 | MA | Strong Buy |